105 related articles for article (PubMed ID: 8714079)
1. Tamoxifen increases the proliferation of human endometrial stromal cells in in vitro. A model for evaluation of endometrial hyperplasia.
Bhargava Periwal S; Farooq A; Bhargava VL; Bhatla N; Vij U; Murugesan K
Indian J Exp Biol; 1995 Dec; 33(12):977-9. PubMed ID: 8714079
[TBL] [Abstract][Full Text] [Related]
2. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
3. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
Pole JC; Gold LI; Orton T; Huby R; Carmichael PL
Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia.
Erdemoglu E; Güney M; Giray SG; Take G; Mungan T
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):195-9. PubMed ID: 19501448
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
Bläuer M; Heinonen PK; Rovio P; Ylikomi T
Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
8. [The effect of danazol and tamoxifen on endometrial hyperplasia].
Soh E
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen modulates apoptotic pathways in primary endometrial cell cultures.
Stackievicz R; Drucker L; Radnay J; Beyth Y; Yarkoni S; Cohen I
Clin Cancer Res; 2001 Feb; 7(2):415-20. PubMed ID: 11234898
[TBL] [Abstract][Full Text] [Related]
10. [Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients].
Yokosuka K; Teshima H; Katase K; Fujimoto I; Yamauchi K; Hasumi K; Tatsuki Y
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):125-32. PubMed ID: 7706853
[TBL] [Abstract][Full Text] [Related]
11. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
12. Morphologic changes in the endometrium associated with the use of the mirena coil: a retrospective study of 106 cases.
Hejmadi RK; Chaudhri S; Ganesan R; Rollason TP
Int J Surg Pathol; 2007 Apr; 15(2):148-54. PubMed ID: 17478768
[TBL] [Abstract][Full Text] [Related]
13. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
14. The influence of insulin on secretion of IGF-I and IGFBP-I in cultures of human endometrial stromal cells.
Lin J; Li R; Zhou J
Chin Med J (Engl); 2003 Feb; 116(2):301-4. PubMed ID: 12775252
[TBL] [Abstract][Full Text] [Related]
15. The effects of tamoxifen on the uterus.
Ismail SM
Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
[TBL] [Abstract][Full Text] [Related]
16. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
Cohen I
Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
[TBL] [Abstract][Full Text] [Related]
17. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
18. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
Kennedy MM; Baigrie CF; Manek S
Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]